findmyKOL
Clinical trialNCT07062354Enrolling, by, invitationPhase 2Interventional

Combined Amivantamab, Carboplatin and Paclitaxel in Unresectable Locally Recurrent or Metastatic Head and Neck Cancer

SponsorSWOG Cancer Research NetworkEnrollment50Head &Amp; Neck CancerHead &Amp; Neck Squamous Cell Carcinoma
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This research study is for people who have head and neck cancer that has come back or spread to other places in the body.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Arizona Cancer Center

    Tucson, Arizona, United States

  • Uci Health - Chao Family Ccc & Ambulatory Care

    Irvine, California, United States

  • Uc Irvine Medical Center

    Orange, California, United States

  • University of Michigan Rogel Cancer Center

    Ann Arbor, Michigan, United States

  • Karmanos Cancer Institute

    Detroit, Michigan, United States

  • Weisberg Cancer Treatment Center

    Farmington Hills, Michigan, United States

  • University of Nebraska Medical Center

    Omaha, Nebraska, United States

  • Medical Univ of South Carolina

    Charleston, South Carolina, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Amivantamab Subcutaneous and Co-Formulated with Recombinant Human Hyaluronidase
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
25 Mar 2026
Primary completion
31 Oct 2028
Completion
31 Oct 2029
Last update posted
11 Aug 2026
Registered enrollment
50
Registry id
NCT07062354
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.